Overview

Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

Status:
Terminated

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

This research study plans to evaluate the use of atorvastatin in patients with coronary artery disease given immediately before PCI and whether it will decrease the amount of heart damage after PCI.

Phase:

N/A

Details

Lead Sponsor:

Indiana University School of Medicine

Collaborator:

National Center for Research Resources (NCRR)

Treatments:

Atorvastatin
Atorvastatin Calcium